Class II · Moderate risk
B-Complex W/Methyl B12/Lido W/Pres
Lack of Assurance of Sterility
FDA Drug Recalls
18,003 recalls, newest first
Class II · Moderate risk
B-Complex W/Cyano B12 W/Pres.
Lack of Assurance of Sterility
Class II · Moderate risk
B-Complex 50 in Nacl 0.9% W/Pres.
Lack of Assurance of Sterility
Class II · Moderate risk
B-Complex 50 in Nacl 0.9%
Lack of Assurance of Sterility
Class II · Moderate risk
B-Complex Without B12 W/Pres
Lack of Assurance of Sterility
Class II · Moderate risk
B-Complex Without B12
Lack of Assurance of Sterility
Class II · Moderate risk
B-COMPLEX (Lieberman)
Lack of Assurance of Sterility
Class II · Moderate risk
B-Complex #3 W/Pres
Lack of Assurance of Sterility
Class II · Moderate risk
B-Complex #3
Lack of Assurance of Sterility
Class III · Low risk
Hyoscyamine Sulfate Sublingual Tablets
Chemical Contamination: Bottles may contain broken dessicants
Class I · High risk
Super Samurai-X
Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements
Class I · High risk
Ginseng Power-X
Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements
Class I · High risk
Ninja-X
Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements
Class I · High risk
Tiger-X
Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements
Class II · Moderate risk
aloe SPORT liniment TOPICAL ANALGESIC 8 fl oz. tube
CGMP Deviations
Class II · Moderate risk
1% Clotrimazol cream
CGMP Deviations
Class II · Moderate risk
VERMOX Tablets 500 mg
CGMP Deviations
Class II · Moderate risk
VERMOX Tablets 100 mg
CGMP Deviations
Class II · Moderate risk
tabcin NOCHE
CGMP Deviations
Class II · Moderate risk
tabcin ACTIVE M.R. Capsules
CGMP Deviations
Class II · Moderate risk
Tazorac (tazarotene)
Failed Content Uniformity Specifications.
Class II · Moderate risk
Tazorac (tazarotene)
Failed Content Uniformity Specifications.
Class II · Moderate risk
Coppertone SUNSCREEN LOTION
Labeling; Product Contains Undeclared API (Oxybenzone)
Class II · Moderate risk
Bromocriptine Mesylate Capsules USP
Failed impurities/degradation specifications: Out of specification results noticed in related substance test during analysis of 24 months long term (25 degree Celsius /65% RH) stability samples of two batches.
Class II · Moderate risk
Vancomycin Hydrochloride for Injection
Presence of Particulate Matter: Cardboard